Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kanz

Showing results (171-180 of 241) with videos related to

Pageof 25
Sort By:
Blood|May 15, 1992
Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I studyA Ganser, A Lindemann, O G Ottmann, et al.
European Journal of Immunology|March 1, 1996
Generation of antigen-presenting cells for soluble protein antigens ex vivo from peripheral blood CD34+ hematopoietic progenitor cells in cancer patientsP Fisch, G Köhler, A Garbe, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 2005
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancerJ Wierecky, C Kollmannsberger, I Boehlke, et al.
Deutsche Medizinische Wochenschrift (1946)|April 30, 2013
[Endocrine abnormalities in a young patient with metastatic cancer - case 3/2013]M Heni, B Besemer, M Guthoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinomaH Hebart, C Erley, B Kaskas, et al.
Leukemia|October 15, 2010
Immune reconstitution after haploidentical hematopoietic cell transplantation: impact of reduced intensity conditioning and CD3/CD19 depleted graftsB Federmann, M Hägele, M Pfeiffer, et al.
International Journal of Cancer|December 22, 1999
Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular Cancer Study Group (GTCSG)C Bokemeyer, C Kollmannsberger, A Harstrick, et al.
British Journal of Haematology|October 1, 1996
CMV infection after allogeneic bone marrow transplantation is associated with the occurrence of various autoantibodies and monoclonal gammopathiesH Hebart, H Einsele, R Klein, et al.
Oncology Reports|October 18, 2001
Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphomaH Dittmann, M Sokler, C Kollmannsberger, et al.
Anti-Cancer Drugs|October 19, 2000
Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancerC Kollmannsberger, A Gerl, N Schleucher, et al.
Pageof 25

Showing results (171-180 of 241) with videos related to

Sort By:
Pageof 25
Blood|May 15, 1992
Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony-stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I studyA Ganser, A Lindemann, O G Ottmann, et al.
European Journal of Immunology|March 1, 1996
Generation of antigen-presenting cells for soluble protein antigens ex vivo from peripheral blood CD34+ hematopoietic progenitor cells in cancer patientsP Fisch, G Köhler, A Garbe, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 2005
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancerJ Wierecky, C Kollmannsberger, I Boehlke, et al.
Deutsche Medizinische Wochenschrift (1946)|April 30, 2013
[Endocrine abnormalities in a young patient with metastatic cancer - case 3/2013]M Heni, B Besemer, M Guthoff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
Positron emission tomography helps to diagnose tumor emboli and residual disease in choriocarcinomaH Hebart, C Erley, B Kaskas, et al.
Leukemia|October 15, 2010
Immune reconstitution after haploidentical hematopoietic cell transplantation: impact of reduced intensity conditioning and CD3/CD19 depleted graftsB Federmann, M Hägele, M Pfeiffer, et al.
International Journal of Cancer|December 22, 1999
Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular Cancer Study Group (GTCSG)C Bokemeyer, C Kollmannsberger, A Harstrick, et al.
British Journal of Haematology|October 1, 1996
CMV infection after allogeneic bone marrow transplantation is associated with the occurrence of various autoantibodies and monoclonal gammopathiesH Hebart, H Einsele, R Klein, et al.
Oncology Reports|October 18, 2001
Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphomaH Dittmann, M Sokler, C Kollmannsberger, et al.
Anti-Cancer Drugs|October 19, 2000
Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancerC Kollmannsberger, A Gerl, N Schleucher, et al.
Pageof 25